Subdermal Contraceptive Implants Market Trends Pegged for Robust Expansion by 2027

Subdermal Contraceptive Implants Market: Introduction

Subdermal contraceptive implant is a tiny, thin rod about the size of a matchstick. The implant releases hormones slow and stable into the body to prevent pregnancy. Subdermal contraceptive implant helps to prevent pregnancy for one to five years. The protection period depends upon specific progestin and the type of polymer.
Advantages of subdermal contraceptive implant include long-term contraceptive action without requiring the provider's or user's attention, low dose of highly effective contraception without the use of estrogen, and fertility is readily reversible after the removal of implant.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Subdermal Contraceptive Implants Market Report

Key Drivers and Restraints of Global Subdermal Contraceptive Implants Market

Rise in awareness about various birth control methods, introduction of several modern contraceptives in the market, and high per capita income are the major factors driving the global subdermal contraceptive implants market. According to the Guttmacher Institute, in 2018, nearly 21 million women needed publicly funded contraceptive services in the U.S. According to the Centers for Disease Control and Prevention, in 2017, around 214 million women of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method.
Recently, the UN collaborated with NGOs to provide contraceptive implants in underdeveloped countries at low price. This acts as a major driver of the market. Additionally, increase in the use of long-term contraception methods in developing countries and surge in awareness about contraception are likely to propel the global market.

Etonogestrel Implant to Witness Significant Demand

Based on type, the global subdermal contraceptive implants market can be segmented into etonogestrel implant, levonorgestrel implant, and others
The etonogestrel implant segment accounted for the largest share of the global subdermal contraceptive implants market in 2018. The segment is projected to dominate the global subdermal contraceptive implants market during the forecast period, as the implant is safe during breast feeding and improves symptoms of dysmenorrhea and endometriosis.

Hospitals Segment to Witness Significant Growth

In terms of end-user, the global subdermal contraceptive implants market can be divided into hospitals, clinics, and others

The hospitals segment accounted for the largest market share in terms of revenue in 2018 and is anticipated to grow at a rapid pace during the forecast period. This can be attributed to increase in number of subdermal contraceptive implant procedures performed in hospitals.

North America to Dominate Global Subdermal Contraceptive Implants Market

In terms of region, the global subdermal contraceptive implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global subdermal contraceptive implants market in 2018 and the trend is expected to continue during the forecast period. The region’s dominance can be attributed to increase in number of abortions, high number of unwanted pregnancies, presence of key market players in the region, greater affordability, and rise in demand for technologically advanced products. According to the Guttmacher Institute, in 2017, 862,000 abortions were carried out in U.S.
The market in Asia Pacific is likely to experience strong growth during the forecast period, owing to increase in adoption of new products, rise in awareness about contraceptives and STIs, and surge in disposable income in emerging countries such as India, China, and others.

Looking for Regional Analysis or Competitive Landscape in Subdermal Contraceptive Implants Market, Ask for a Customized Report

Key Manufacturers Operating in Global Market

The global subdermal contraceptive implants market was highly fragmented in 2018. Key manufacturers operating in the global market are:

Bayer AG
Merck & Co. Inc.
Shanghai Dahua Pharmaceutical Co., Ltd.

Global Subdermal Contraceptive Implants Market: Research Scope

Global Subdermal Contraceptive Implants Market, by Type

Etonogestrel Implant
Levonorgestrel Implant
Others

Global Subdermal Contraceptive Implants Market, by End-user

Hospitals
Clinics
Others

Global Subdermal Contraceptive Implants Market, by Region

U.S.
Canada

Europe

Germany
U.K.
France
Italy
Spain
Rest of Europe

Asia Pacific

China
India
Japan
Australia & New Zealand
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC Countries
South Africa
Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75805

More Trending Reports by Transparency Market Research –

Fetal Monitoring Systems Market: https://www.prnewswire.com/news-releases/innovation-in-wearable-devices-driving-fetal-monitoring-systems-market-to-upward-growth-trajectory-tmr-301015185.html